Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,870.30

15.32 (0.83%)

06:26
06/14/19
06/14
06:26
06/14/19
06:26

Amazon seeks to rejuvenate lending business, Financial Times reports

Amazon Lending, which offered annual loans at interest rates of 6%-17%, has experienced slowed growth, Nicholas Megaw of Financial Times reported, citing Amazon's most recent annual report. Outstanding loans nearly doubled between the end of 2015 and end of 2016, but growth fell to just 4.7% the following year and only 2.6% in 2018. Amazon appears to be preparing for a second push in the lending business, having placed job ads for a number of positions across Europe, Asia and Seattle. The listings reportedly suggest that the company has aims to revitalize its existing loan products, expand into new countries and disrupt the finance industry. Reference Link

  • 25

    Jun

  • 10

    Jul

AMZN Amazon.com
$1,870.30

15.32 (0.83%)

06/12/19
WEDB
06/12/19
NO CHANGE
Target $100
WEDB
Outperform
GrubHub best positioned amid Amazon Restaurants shutdown, says Wedbush
Wedbush analyst Ygal Arounian notes that Amazon (AMZN) announced that it will shut down Amazon Restaurants in the U.S., which he views as further evidence that rationality is creeping into the U.S. 3P food takeout market. The analyst sees GrubHub (GRUB) as the best positioned to maintain/regain strength in this environment, as it is the only U.S. third-party takeout provider that is profitable and has always been rational in only adding LTV positive customers. Arounian reiterates an Outperform rating and $100 price target on GrubHub's shares, but adds that he sees "significant room" for multiple expansion if investors regain confidence in this sector.
06/12/19
WEDB
06/12/19
NO CHANGE
Target $155
WEDB
Outperform
Microsoft momentum not slowing down, says Wedbush
Wedbush analyst Daniel Ives believes Microsoft (MSFT) remains in an "enviable position" heading into the rest of 2019 and 2020 on the heels of its cloud success and is firing on all cylinders around its Office 365 and Azure strategic vision based on his recent checks. So far in the June quarter the analyst is seeing a "clear acceleration" of larger and more strategic enterprise cloud deals as believes "Redmond is poised to win the lion's share" of the next phase of cloud deployments versus Amazon (AMZN). The shift to cloud is a major secular trend that is significantly benefiting Microsoft in the field and should continue its momentum heading into the next 12-18 months, he contends. Ives reiterates an Outperform rating and $155 price target on Microsoft's shares.
06/12/19
BOFA
06/12/19
NO CHANGE
Target $108
BOFA
Buy
Less competition for GrubHub amid Amazon Restaurants exit, says BofA/Merrill
Amazon's (AMZN) discontinuation of its U.S. restaurant delivery service removes the threat to GrubHub (GRUB) of Amazon expanding its online food delivery business organically, BofA/Merrill analyst Nat Schindler tells investors in a research note. Schindler notes that online food delivery is a large, fragmented, and rapidly evolving market with significant capital infusion from public and private investors, and Amazon may be shifting from "build" to "partner or buy" in this market. The analyst contends that while GrubHub has lost some market share recently, he sees growth as healthy overall, and says the disconnect between rising private valuations and recent declines in GrubHub's market cap may create an opportunity.
06/12/19
KEYB
06/12/19
NO CHANGE
Target $190
KEYB
Overweight
FedEx price target lowered to $190 from $215 at KeyBanc
KeyBanc analyst Todd Fowler lowered his price target for FedEx (FDX) to $190 from $215 ahead of Q4 to reflect trade uncertainty and some impact of the non-renewal of the U.S. domestic Express contract with Amazon (AMZN), partially offset by improved Ground margins, voluntary buyout benefits, and modest Freight contribution. The analyst reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

ESPR

Esperion

$48.64

-0.36 (-0.73%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
Esperion reaches $200M revenue-based funding agreement with Oberland Capital »

Esperion and an investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDNA

CareDx

$34.68

-0.99 (-2.78%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Hot Stocks
CareDx 'applauds' progress in Medicare immunosuppressive medication legislation »

CareDx said it,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAN

Dana

$18.38

0.74 (4.20%)

08:27
06/27/19
06/27
08:27
06/27/19
08:27
Initiation
Dana initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.00

-1.01 (-1.74%)

08:26
06/27/19
06/27
08:26
06/27/19
08:26
Periodicals
Huawei in talks with Verizon over royalty payments for patents, CNBC reports »

Huawei is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 09

    Jul

  • 01

    Aug

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Hot Stocks
Dova Pharmaceuticals announces FDA approval of sNDA for DOPTELET »

Dova Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 30

    Jun

WBC

Wabco

$131.95

-0.23 (-0.17%)

08:25
06/27/19
06/27
08:25
06/27/19
08:25
Conference/Events
Wabco to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

TSLA

Tesla

$219.22

-0.47 (-0.21%)

08:24
06/27/19
06/27
08:24
06/27/19
08:24
Initiation
Tesla initiated  »

Tesla initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$1.79

-0.04 (-2.19%)

08:23
06/27/19
06/27
08:23
06/27/19
08:23
Hot Stocks
Ovid Therapeutics initiates Phase 3 trial of OV101 »

Ovid Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$22.20

0.35 (1.60%)

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Hot Stocks
Kratos Defense receives $4.1M C5ISR system contract award »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Recommendations
Verrica Pharmaceuticals analyst commentary  »

Verrica reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$19.23

0.67 (3.61%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Initiation
Delphi Technologies initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$6.23

0.04 (0.65%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Hot Stocks
Entasis Therapeutics announces new results on antimicrobial programs »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$183.53

1.54 (0.85%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$77.84

0.82 (1.06%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.46

0.99 (1.58%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$41.55

0.05 (0.12%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Initiation
BorgWarner initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

XLY

Consumer Discretionary Sector SPDR

$118.12

0.35 (0.30%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.80

-0.12 (-0.21%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADAP

Adaptimmune

$4.07

0.07 (1.75%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Hot Stocks
Adaptimmune CFO Adrian Rawcliffe to succeed James Noble as CEO »

Adaptimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BC

Brunswick

$45.29

0.2 (0.44%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$59.33

-1.3 (-2.14%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Conference/Events
Dova Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.